Georges Horkoss , Joey El Khoury , Rami Halabi , Anthony Kanbar , Serge Assaf , Anthony Mina , Sabine El Breidi , Charbel Dabal , Charbel El Hachem , Maher Abdessater , Rodrigue Saad , Antoine Kassis , Raghid El Khoury
{"title":"Factors influencing smoking cessation in Lebanese patients with bladder cancer: A cross sectional study","authors":"Georges Horkoss , Joey El Khoury , Rami Halabi , Anthony Kanbar , Serge Assaf , Anthony Mina , Sabine El Breidi , Charbel Dabal , Charbel El Hachem , Maher Abdessater , Rodrigue Saad , Antoine Kassis , Raghid El Khoury","doi":"10.1016/j.ctarc.2025.100879","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Bladder cancer (BCa) is a very common urological cancer. Literature showed smoking as a main risk factor for BCa however patients may not be well-informed about the relation between smoking and BCa. Urologists play a crucial role in educating patients about smoking risks and encouraging cessation. The objective is to discover sociodemographic factors that influence the success rate of smoking cessation and other behavioral changes in a sample of smoking Lebanese patients diagnosed with BCa.</div></div><div><h3>Methods</h3><div>A cross sectional study was conducted using a phone survey composed of 53 questions assessing the patients’ knowledge that they had or received from their treating physician about smoking as risk factor for BCa. A sample of patients diagnosed with BCa between 2015 and 2020 were contacted and data was collected between the months of September 2022 and May 2023. Inclusion criteria consisted of adult patients with a diagnosis of BCa and a history of smoking while exclusion criteria consisted of unreachable patients. 260 patients were chosen, 182 patients responded making the response rate 70 %</div></div><div><h3>Results</h3><div>Our sample size consisted of 182 patients was composed of 143 males (78.6 %) and 39 females (21.4 %), 97 (53.3 %) are currently smokers of which 50 (51.5 %) tried but failed, 41 (42.3 %) found no benefit in stopping and 6 (6.2 %) were not counseled. 145 patients (79.7 %) knew about smoking as a risk factor for BCa, with only 6 (3.3 %) knowing before their diagnosis. The multivariate analysis has shown that women (<em>p</em> = 0.010), patients with higher educational level (<em>p</em> = 0.004) tend to stop smoking after diagnosis with BCa more than men and people with lower educational level. Also there was a positive correlation between urologist counseling and smoking cessation (<em>p</em> = 0.03).</div></div><div><h3>Conclusion</h3><div>These findings showed that people had little knowledge about smoking as risk factor for BCa. A need for nationwide awareness campaigns about smoking risks specially targeting lower educational level patients and men or implicating stricter laws for smoking. Also a need of improving in smoking cessation counseling of urologists.</div></div>","PeriodicalId":9507,"journal":{"name":"Cancer treatment and research communications","volume":"43 ","pages":"Article 100879"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment and research communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468294225000176","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Bladder cancer (BCa) is a very common urological cancer. Literature showed smoking as a main risk factor for BCa however patients may not be well-informed about the relation between smoking and BCa. Urologists play a crucial role in educating patients about smoking risks and encouraging cessation. The objective is to discover sociodemographic factors that influence the success rate of smoking cessation and other behavioral changes in a sample of smoking Lebanese patients diagnosed with BCa.
Methods
A cross sectional study was conducted using a phone survey composed of 53 questions assessing the patients’ knowledge that they had or received from their treating physician about smoking as risk factor for BCa. A sample of patients diagnosed with BCa between 2015 and 2020 were contacted and data was collected between the months of September 2022 and May 2023. Inclusion criteria consisted of adult patients with a diagnosis of BCa and a history of smoking while exclusion criteria consisted of unreachable patients. 260 patients were chosen, 182 patients responded making the response rate 70 %
Results
Our sample size consisted of 182 patients was composed of 143 males (78.6 %) and 39 females (21.4 %), 97 (53.3 %) are currently smokers of which 50 (51.5 %) tried but failed, 41 (42.3 %) found no benefit in stopping and 6 (6.2 %) were not counseled. 145 patients (79.7 %) knew about smoking as a risk factor for BCa, with only 6 (3.3 %) knowing before their diagnosis. The multivariate analysis has shown that women (p = 0.010), patients with higher educational level (p = 0.004) tend to stop smoking after diagnosis with BCa more than men and people with lower educational level. Also there was a positive correlation between urologist counseling and smoking cessation (p = 0.03).
Conclusion
These findings showed that people had little knowledge about smoking as risk factor for BCa. A need for nationwide awareness campaigns about smoking risks specially targeting lower educational level patients and men or implicating stricter laws for smoking. Also a need of improving in smoking cessation counseling of urologists.
期刊介绍:
Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.